Low Expression of miR-448 Induces EMT and Promotes Invasion by Regulating ROCK2 in Hepatocellular Carcinoma
- PMID: 25969175
- DOI: 10.1159/000430114
Low Expression of miR-448 Induces EMT and Promotes Invasion by Regulating ROCK2 in Hepatocellular Carcinoma
Abstract
Background/aims: miR-448 has been reported to exhibit abnormal expression in hepatocellular carcinoma (HCC), however, the essential role of miR-448 in HCC progression is still unclear.
Methods: real-time PCR was used to detect the expression of miRNAs and candidate genes in HCC samples (n=117). miR-448 mimics and inhibitor were tansfected in human HCC cells. The transwell assay was used to examine the cell invasive ability. The regulation mechanism was confirmed by luciferase reporter assay. The markers of EMT were detected by using Western blot.
Results: miR-448 was decreased in HCC samples and associated with HCC development. Inhibition of miR-448 significantly promoted cell invasion, while the effect of miR-448 up-regulation was reverse. miR-448 could regulate ROCK2 in hepatocellular carcinoma. Knockdown of ROCK2 expression partially reversed the effect of miR-448 inhibitor. Abnormal expression of miR-448 could regulate the markers of epithelial-mesenchymal transition (EMT).
Conclusions: miR-448 may contribute to the progression of HCC via regulating ROCK2 expression.
© 2015 S. Karger AG, Basel.
Similar articles
-
MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.Yonsei Med J. 2019 Mar;60(3):267-276. doi: 10.3349/ymj.2019.60.3.267. Yonsei Med J. 2019. PMID: 30799589 Free PMC article.
-
Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.Mol Cancer. 2017 Jul 17;16(1):123. doi: 10.1186/s12943-017-0702-z. Mol Cancer. 2017. PMID: 28716020 Free PMC article.
-
miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.Biomed Pharmacother. 2018 Jul;103:1632-1642. doi: 10.1016/j.biopha.2018.03.005. Epub 2018 May 7. Biomed Pharmacother. 2018. PMID: 29864952
-
miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.Biochem Biophys Res Commun. 2015 Jul 31;463(3):315-21. doi: 10.1016/j.bbrc.2015.05.062. Epub 2015 May 27. Biochem Biophys Res Commun. 2015. PMID: 26022123
-
DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway.Cell Prolif. 2019 Jul;52(4):e12628. doi: 10.1111/cpr.12628. Epub 2019 Apr 30. Cell Prolif. 2019. PMID: 31038266 Free PMC article.
Cited by
-
miR-185-5p targets ROCK2 and inhibits cell migration and invasion of hepatocellular carcinoma.Oncol Lett. 2019 Jun;17(6):5087-5093. doi: 10.3892/ol.2019.10144. Epub 2019 Mar 13. Oncol Lett. 2019. PMID: 31105794 Free PMC article.
-
microRNAs Make the Call in Cancer Personalized Medicine.Front Cell Dev Biol. 2017 Sep 22;5:86. doi: 10.3389/fcell.2017.00086. eCollection 2017. Front Cell Dev Biol. 2017. PMID: 29018797 Free PMC article. Review.
-
S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2.Tumour Biol. 2016 Mar;37(3):2925-32. doi: 10.1007/s13277-015-3709-3. Epub 2015 Sep 26. Tumour Biol. 2016. PMID: 26409452
-
MiR-448 promotes vascular smooth muscle cell proliferation and migration in through directly targeting MEF2C.Environ Sci Pollut Res Int. 2017 Oct;24(28):22294-22300. doi: 10.1007/s11356-017-9771-1. Epub 2017 Aug 11. Environ Sci Pollut Res Int. 2017. PMID: 28799067
-
MiR-448 suppresses cell proliferation and glycolysis of hepatocellular carcinoma through inhibiting IGF-1R expression.J Gastrointest Oncol. 2022 Feb;13(1):355-367. doi: 10.21037/jgo-22-90. J Gastrointest Oncol. 2022. PMID: 35284123 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical